Furthermore, in line with a previous study using osteosarcoma cells [53], an inhibitor of PI3K, LY294002, significantly enhanced the apoptotic effect of genistein and further reduced cell viability, supposing that genistein-mediated apoptotic cell death is achieved by at least blocking the PI3K/Akt signaling pathway. This evidence concerns the gene AKT1 and osteosarcoma.